DAVPX
Price
$37.47
Change
-$0.65 (-1.71%)
Updated
Feb 21 closing price
Net Assets
1.14B
GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

DAVPX vs GFACX

Header iconDAVPX vs GFACX Comparison
Open Charts DAVPX vs GFACXBanner chart's image
Davenport Core Leaders Fund
Price$37.47
Change-$0.65 (-1.71%)
VolumeN/A
Net Assets1.14B
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
DAVPX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DAVPX vs. GFACX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAVPX is a Hold and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. DAVPX (1.15B). DAVPX pays higher dividends than GFACX: DAVPX (0.28) vs GFACX (0.00). DAVPX was incepted earlier than GFACX: DAVPX (27 years) vs GFACX (24 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. DAVPX (19.00). GFACX has a lower initial minimum investment than DAVPX: GFACX (250) vs DAVPX (5000). GFACX (10.15) and DAVPX (10.02) have marching annual gain over last year. DAVPX return over 5 years is better than : 35.26 vs. GFACX (32.83).
DAVPXGFACXDAVPX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years24 years-
Gain YTD3.8242.980128%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.15B304B0%
Annual Yield % from dividends0.280.00-
Returns for 1 year10.0210.1599%
Returns for 3 years23.6217.69134%
Returns for 5 years35.2632.83107%
Returns for 10 years91.2355.63164%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding